Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Diffusion Pharmaceuticals Q3 EPS $(1.37) Up From $(5.99) YoY

Author: Benzinga Newsdesk | November 14, 2022 04:41pm
Diffusion Pharmaceuticals (NASDAQ:DFFN) reported quarterly losses of $(1.37) per share. This is a 77.13 percent increase over losses of $(5.99) per share from the same period last year.

Posted In: DFFN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist